Physician profile
Frederico Xavier
NPI 1669751053
$96,342.35
in general payments reported to CMS, 2019-2025
16 companies · $18K in 2025
The $18K reported for 2025 was more than what 90% of Pediatric Hematology-Oncology providers received nationally (typical 2025 total: $207).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,688 · 2020: $1,735 · 2021: $150 · 2022: $13K · 2023: $24K · 2024: $35K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $67K · Travel and Lodging: $5,269 · Food and Beverage: $4,546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $66,944.47 |
| Travel and Lodging | $5,269.32 |
| Food and Beverage | $4,545.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $50,085.60 | 2022-2025 | |
| Genentech USA, INC. | $29,578.82 | 2019-2025 | Hemlibra |
| Sanofi-Aventis U.S. LLC | $10,059.56 | 2024 | |
| Hema Biologics, LLC | $6,085.20 | 2023-2025 | Sevenfact, Sevenfact |
| Genentech, INC. | $189.55 | 2021-2025 | Hemlibra |
| Biomarin Pharmaceutical INC. | $94.11 | 2023-2025 | Roctavian, Roctavian |
| Stryker Corporation | $55.07 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $38.94 | 2024 | |
| Spark Therapeutics, INC. | $31.64 | 2025 | |
| Mindray Ds USA, INC. | $29.11 | 2024 | Te7 Max, Te X |
| Kedrion Biopharma, INC. | $28.69 | 2024 | Rhogam Ultra-Filtered Plus, Gammaked, Albuked |
| Takeda Pharmaceuticals U.S.A., INC. | $24.08 | 2024 | |
| Novo Nordisk INC | $21.58 | 2025 | |
| Csl Behring | $20.40 | 2023 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederico Xavier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.